About
Ardelyx, Inc. is a biopharmaceutical company that develops and commercializes novel medicines focusing on chronic kidney disease with hyperphosphatemia and irritable bowel syndrome with constipation (IBS-C).
Explore Ardelyx, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.